###begin article-title 0
Ets-2 and C/EBP-beta are important mediators of ovine trophoblast Kunitz domain protein-1 gene expression in trophoblast
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
The trophoblast Kunitz domain proteins (TKDPs) constitute a highly expressed, placenta-specific, multigene family restricted to ruminant ungulates and characterized by a C-terminal "Kunitz" domain, preceded by one or more unique N-terminal domains. TKDP-1 shares an almost identical expression pattern with interferon-tau, the "maternal recognition of pregnancy protein" in ruminants. Our goal here has been to determine whether the ovine (ov) Tkdp-1 and IFNT genes possess a similar transcriptional code.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 335 342 335 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT</italic>
###xml 694 703 694 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 727 735 727 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 863 870 860 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 969 976 963 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
The ovTkdp-1 promoter has been cloned and characterized. As with the IFNT promoter, the Tkdp-1 promoter is responsive to Ets-2, and promoter-driven reporter activity can be increased over 700-fold in response to over-expression of Ets-2 and a constitutively active form of protein Kinase A (PKA). Unexpectedly, the promoter element of Tkdp-1 responsible for this up-regulation, unlike that of the IFNT, does not bind Ets-2. However, mutation of a CCAAT/enhancer binding element within this control region not only reduced basal transcriptional activity, but prevented Ets-2 as well as cyclic adenosine 5'-monophosphate (cAMP)/PKA and Ras/mitogen-activated protein kinase (MAPK) responsiveness. In vitro binding experiments and in vivo protein-protein interaction assays implicated CCAAT/enhancer binding protein-beta (C/EBP-beta) as involved in up-regulating the Tkdp-1 promoter activity. A combination of Ets-2 and C/EBP-beta can up-regulate expression of the minimal Tkdp-1 promoter as much as 930-fold in presence of a cAMP analog. An AP-1-like element adjacent to the CCAAT enhancer, which binds Jun family members, is required for basal and cAMP/ C/EBP-beta-dependent activation of the gene, but not for Ets-2-dependent activity.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT</italic>
This paper demonstrates how Ets-2, a key transcription factor for trophoblast differentiation and function, can control expression of two genes (Tkdp-1 and IFNT) having similar spatial and temporal expression patterns via very different mechanisms.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 392 402 392 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 404 419 404 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. melanogaster</italic>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 923 924 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 925 926 925 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 927 928 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 929 930 929 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 392 402 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
###xml 404 419 <span type="species:ncbi:7227">D. melanogaster</span>
The trophoblast Kunitz domain proteins are a family of closely related gene products uniquely expressed by trophoblast of ruminant ungulates [1,2]. Each protein is characterized by the presence of a well-conserved, carboxyl-terminal ~65 amino acid domain, typically found in the Kunitz family of serine peptidase inhibitors. The Kunitz domain is an evolutionary conserved module, existing in C. elegans, D. melanogaster, and all known vertebrates, that generally functions as a serine peptidase inhibitor, although functions unrelated to peptidase inhibition have also been documented [3-6]. This independently folding unit is preceded by one or more "repeat" sequences of ~80 amino acids of unknown function, which have similar but not identical sequences [1,2]. TKDPs represent one of the most abundant classes of secretory proteins produced by the conceptus during the peri-implantation period and throughout gestation [1,2,7,8]. Although the function of these proteins remains unclear, their unusually high expression at the interface between the maternal and fetal systems and the presence of conserved Kunitz units at their carboxyl termini strongly suggest an important role during pregnancy that relates to the evolution of the non-invasive placental type encountered in ruminant species.
###end p 9
###begin p 10
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 753 754 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 851 852 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 853 855 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 282 288 <span type="species:ncbi:9913">bovine</span>
###xml 586 592 <span type="species:ncbi:9913">cattle</span>
###xml 597 602 <span type="species:ncbi:9940">sheep</span>
###xml 746 751 <span type="species:ncbi:9940">sheep</span>
Although expressed abundantly, the concentrations of different TKDP mRNAs do not remain constant over the course of pregnancy. Instead, expression of each TKDP appears to be quite tightly regulated and confined to specific stages of fetal development. For example, ovTKDP-1 and its bovine ortholog (boTKDP-1) are expressed significantly for just a few days preceding the period when the trophoblast begins to adhere tightly to the uterine wall [2] In this respect, the temporal expression pattern of TKDP-1 and that of IFN-tau, the major signal for maternal recognition of pregnancy in cattle and sheep are remarkably similar. For example, both TKDP-1 and IFN-t are secreted by the trophoblast mononuclear cells during days 13-21 of pregnancy in sheep [7]. In view of the physiological importance of IFN-tau in ensuring the survival of the conceptus [9,10] and the fact that both TKDP-1 and IFN-tau are up-regulated massively and simultaneously at a particular critical time when many embryos are lost, it seems likely that ovTKDP-1 has some function important for mediating maternal-conceptus interaction during the peri-attachment/implantation period of conceptus development.
###end p 10
###begin p 11
###xml 122 137 120 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 and IFNT</italic>
###xml 401 408 399 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 527 531 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT</italic>
The strikingly similar spatial-temporal expression pattern of TKDP-1 and IFN-tau raises the possibility that these genes (Tkdp-1 and IFNT) representing these proteins are controlled by very similar transcriptional mechanisms and possibly share common transcription factor binding elements in their promoter regions. The major focus of the current research has been to gain insight into the control of Tkdp-1 gene expression and to determine whether the mechanisms involved resembled those associated with the regulation of the IFNT. One important goal has been to elucidate whether or not there is a common theme to the transcriptional regulation of genes that are first expressed as the trophoblast begins to differentiate functionally early in pregnancy and secrete its signature gene products. The outcome of this research could, therefore, have implications to the establishment and/or maintenance of pregnancy and the specification of trophoblast function in all mammals.
###end p 11
###begin p 12
###xml 107 116 107 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 124 133 124 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
The data presented here demonstrates Ets-2 having an important role in activating the transcription of the ovTkdp-1 gene in in vitro cell culture systems. However, unlike the IFNT promoter, which directly interacts with Ets-2 via consensus Ets-binding site, the Ets-2 effect on the Tkdp-1 promoter is indirect and mediated by protein-protein interaction with C/EBP-beta. In other words, Ets-2-dependent transactivation of genes with nearly identical spatial and temporal expression patterns can be mediated by different mechanisms.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Expression patterns of the ovTKDP-1 and IFN-tau messages during pregnancy
###end title 14
###begin p 15
###xml 94 95 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 405 407 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 217 222 <span type="species:ncbi:9940">sheep</span>
###xml 446 451 <span type="species:ncbi:9940">sheep</span>
Although TKDP-1 and IFN-tau mRNA are expressed within a comparable window of early pregnancy [7], side by side comparisons have not been made. We therefore conducted RT-PCR with equal quantities of RNA extracted from sheep conceptuses collected at different days of early pregnancy. The expression patterns for ovTKDP-1 and ovIFN-tau mRNAs were similar both in magnitude and over developmental time (Fig. 1A). Both transcripts were detectable in sheep conceptuses at day 14 of pregnancy, with concentrations peaking at day 15 and subsequently declining after day 17 to become almost undetectable by day 25 relative to the amplified product derived from the endogenous control, ribosomal protein S25.
###end p 15
###begin title 16
###xml 127 132 <span type="species:ncbi:9606">human</span>
Constitutive transcriptional activities of the truncated promoter-Luciferase (Luc) reporter constructs from the Tkdp-1 gene in human choriocarcinoma JEG-3 cells
###end title 16
###begin p 17
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp</italic>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp</italic>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 1392 1396 1392 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
Different length fragments from 1 Kbp region upstream of the transcription start point (tsp) of the Tkdp-1 gene were used to generate seven sequentially 5/-truncated Tkdp-1 promoter-Luc reporter constructs (1000, 558, 352, 254, 192, 140 and 82 bp from the tsp). These constructs were transiently transfected into JEG-3 cells and their expression compared relative to the Luc activity from the promoter-less pGL2 Basic vector (Fig. 2). All but the 82 bp promoter-reporter constructs were able to drive Luc reporter gene significantly better than the promoter-less reporter construct. The 1000 bp construct had the maximum basal promoter activity, and this activity was reduced significantly when the promoter was shortened to 558 bp. Promoter activity increased again in the 352, 254, 192 and 140 bp constructs, but was never completely restored to that of the 1000 bp construct. These data suggest that there are two enhancer/activator elements present, one distal, between -558 and -1000 bp, and the other more proximal, lying between 140 and 82 bp. There may also be a cryptic repressor element lying between the 558 bp and 352 bp promoter fragments, although another explanation for the poor activity of the 558 construct is that it folds in such a way that it is less easily transcribed than its longer and shorter relatives. Since the 140 bp construct was the shortest one able to drive Luc expression effectively, contained the proximal enhancer element, and included several relevant transcription factor binding sites (see below) our efforts became focused on this control region of the gene.
###end p 17
###begin title 18
Putative transcription factor-binding sites on theTkdp-1 promoter
###end title 18
###begin p 19
###xml 5 6 5 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp </italic>
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boIFNT1 </italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 262 271 262 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 635 639 635 639 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGAA</underline>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 810 811 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 856 863 856 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 984 989 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Fig. 3 illustrates putative transcription factor binding sites within 140 bp upstream of the tsp of the Tkdp-1 promoter that can also be identified within the boIFNT1 proximal promoter (-126 to +50) and have been implicated in the basal expression of IFNT genes in vitro [11,12]. No Ets-2/AP-1 composite enhancer motif comparable to the one essential for IFNT gene transcription is detectable within the proximal 140 bp of the Tkdp-1 promoter, although a number of potential Ets-factor binding elements are present. None of these sites possesses a sequence identical to the Ets-2-binding element found within the IFNT promoter (-79 ACAGGAAGTG -70), although each does possess the central GGA motif that is an invariable feature of all Ets-factor-binding sites [13,14] (Fig. 3 and additional data file 1 - Fig. 1). A possible AP-1 element is present in the Tkdp-1 promoter, but its sequence is different from that of the one placed just upstream of the Ets-2-binding site on all known IFNT genes (TGAGAGA versus TGAG/CTCA) [11].
###end p 19
###begin title 20
Effects of over-expressing Ets family transcription factors on the transcriptional activity of the Tkdp-1 promoter in JEG-3 cells
###end title 20
###begin p 21
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 313 315 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 316 318 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 331 336 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 337 339 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 352 359 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 637 639 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1083 1090 1074 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
Although expressed widely in adult and embryonic tissues, the Ets family transcription factor Ets-2 is crucial for placental development [15]. It is also present in ovine conceptus tissue at the time that IFN-tau is produced and is known to support expression of several genes that are restricted to trophoblast [16-22], including IFNT [23]. Since the Tkdp-1 gene possesses several Ets-like sites within its promoter region, transient transfection experiments were performed to test the effects of over-expressing several Ets family members on the transcriptional activity of the 1000 bp promoter-reporter construct in JEG-3 cells (Fig. 4A). In order to provide roughly comparable expression, each of these Ets expression constructs was driven by the same cytomegalovirus promoter, although protein stability and other variables could not be controlled. Among six different Ets-related transcription factors examined (Ets-1, Ets-2, Elf-1, Fli-1, PEA3, PU.1 and GABP-alpha,-beta) only Ets-1 and Ets-2 had significant ability to up-regulate the transcriptional activity of the 1000 bp Tkdp-1 promoter. Of the two, Ets-2 was clearly the superior (30-fold versus 13-fold).
###end p 21
###begin p 22
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp</italic>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 879 886 879 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 895 899 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
To examine which part of the Tkdp-1 promoter is responsive to Ets-2, an equal amount of three truncated Tkdp-1 promoter-reporter constructs, 1000 bp, 352 bp and 140 bp, was co-transfected into JEG-3 cells with the Ets-2 expression plasmid. Ets-2 over-expression increased Luc activity of all three constructs quite similarly (Fig. 4B), although the 140 bp promoter was slightly more responsive than the 1000 bp promoter (Fig. 4B: 28-fold for 1000 versus 34-fold for 140). These data suggested that the region of the promoter targeted by Ets-2 is within 140 bp of the tsp. We also tested the effect of Ets-2 over-expression on the transcriptional activity of the promoter-less Luc reporter vector (pGL-2 Basic) (data not shown). As expected, Ets-2 had no significant effect on the reporter expression in absence of a promoter, indicating that the Ets-2-mediated activation of the Tkdp-1 promoter-Luc construct is a promoter-specific effect.
###end p 22
###begin p 23
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 364 373 364 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 589 596 589 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 662 671 662 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 906 913 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
Ets-2-mediated activation of the Tkdp-1 promoter was dose-dependent (Fig. 4C). Differences in fold-activation between experiments probably reflect the quality of the plasmid DNA and other variables not easily controlled in transfection studies. A time-course experiment was also performed as a preliminary test to determine whether the Ets-2-responsiveness of the ovTkdp-1 promoter is early or delayed. An early response is indicative of a direct effect while a delayed response would suggest Ets-2-mediated up-regulation of some other transcription factor necessary for expression of the Tkdp-1 gene. When JEG-3 cells, co-transfected with Ets-2 and the 1000 bp ovTkdp-1 promoter constructs, were harvested at various time points after transfection (data not shown), Ets-2-responsiveness of the 1000 bp construct was clearly evident within 6 h of transfection, suggesting that Ets-2 directly activates the Tkdp-1 promoter.
###end p 23
###begin title 24
Ras/MAPK-mediated activation of theTkdp-1 promoter in 3T3 cells
###end title 24
###begin p 25
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 303 310 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 866 873 866 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 1071 1078 1071 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 1218 1225 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
Ets-2 and the related transcription factor Ets-1 bind to specific DNA elements via their Ets domains, but often require activation through Ras/MAPK-dependent phosphorylation at specific residues in order to participate effectively in target gene transcription [11,16,24-28]. To test whether the 1000 bp Tkdp-1 promoter-reporter construct was similarly responsive to MAPK activation, it was co-transfected with a constitutively active Ras expression plasmid in presence and absence of Ets-2 in mouse fibroblast 3T3 cells. These mouse fibroblasts were used because, unlike choriocarcinoma cells, they possess low endogenous levels of Ets-2 and activated Ras [11], so that the effect of over-expression is easily demonstrable. Ras in combination with Ets-2, but not by itself, caused a 21-fold activation of the 1000 bp promoter construct (Fig. 5). This stimulation of Tkdp-1 promoter activity was reduced approximately 96% by treating the transfected cells with the MAPK kinase (MEK1) inhibitor PD98059. If the codon encoding the Ras/MAPK target site, Thr 72, was mutated, Tkdp-1 promoter activity was reduced by about 50% compared to that obtained with the Ras and wild type Ets-2 combination. These data show that the Tkdp-1 promoter can be up-regulated by the Ras/MAPK pathway acting through Ets-2.
###end p 25
###begin title 26
cAMP/PKA-mediated activation of the Tkdp-1 promoter in JEG-3 cells
###end title 26
###begin p 27
###xml 170 181 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG)-&#945; </italic>
###xml 185 190 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </italic>
###xml 205 207 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 208 210 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 216 221 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 222 224 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 363 370 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 510 511 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 519 520 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 140 145 <span type="species:ncbi:9606">human</span>
The cAMP/PKA signaling pathway has been shown to modulate the Ets-dependent activation of several trophoblast-specific genes, including the human chorionic gonadotropin (hCG)-alpha and beta subunit genes [16,17] and IFNT [17]. Treatment of JEG-3 cells with increasing concentrations of the cAMP analog, 8-Br-cAMP, after co-transfecting the cells with the 1000 bp Tkdp-1 promoter-reporter construct and the Ets-2 expression plasmid provided only a 2-3-fold enhancement of the Ets-2 effect (Additional data file 1 - Fig. 2). 8-Br-cAMP alone, i.e. in absence of over-expressed Ets-2, had no significant ability to up-regulate the promoter (data not shown).
###end p 27
###begin p 28
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 435 442 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 593 600 593 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 854 861 854 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1093 1095 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1127 1134 1127 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
One possibility of explaining why 8-Br-cAMP had such a minor effect on the Tkdp-1 promoter was that in JEG-3 cells PKA, the downstream target of cAMP, is present in limiting amounts. Accordingly, the effects of a constitutively active catalytic subunit of PKA were examined. As shown in Fig. 6A, over-expression of the constitutively active catalytic subunit of PKA led to a 120-fold up-regulation of the basal activity of the 1000 bp Tkdp-1 promoter in JEG-3 cells. When Ets-2 was also over-expressed, activity of the promoter was enhanced over 700-fold. The PKA and PKA+Ets-2 effects on the Tkdp-1 promoter activation were inhibited over 95% by expression of a PKA inhibitor (PKI) construct (Fig. 6A). Additionally, substitution of the plasmid expressing the active form of PKA with one with a mutated catalytic site (mutPKA) failed to up-regulate the Tkdp-1 promoter (Fig. 6A). Finally, treatment of transfected cells with a pharmacological PKA inhibitor, H89, caused dramatic reduction in promoter activity, both in absence and presence of Ets-2, in a concentration-dependent manner (Fig. 6B). These data indicate that the Tkdp-1 promoter is responsive to the cAMP/PKA signal transduction pathway and that Ets-2 acts synergistically with this pathway to up-regulate this promoter.
###end p 28
###begin title 29
Indirect interaction between Ets-2 and the Tkdp-1 promoter
###end title 29
###begin p 30
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 367 374 367 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1040 1042 1040 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
As mentioned previously, other than having the core GGA sequence, none of the putative Ets-like sites within the Tkdp-1 promoter showed a close match with either the consensus Ets-2-binding motif (C/A)(C/A)GGA(A/T)(A/G) or the well defined, functional site (CAGGAAG) in the IFNT promoter. In order to determine whether any of these putative Ets-like sites within the Tkdp-1 promoter binds Ets-2, competition electrophoretic mobility shift assay (EMSA) was performed. The 140 bp minimal promoter was chosen because it had multiple potential Ets-like sites (Fig. 3) and provided full Ets-2 responsiveness (Fig. 4B). Initial experiments in which we employed EMSA to demonstrate an interaction between recombinant Ets-2 and oligonucleotides representing these potential Ets-binding sequences failed to reveal the formation of any complexes (data not shown). As shown in Fig. 7, none of the six potential competitor oligonucleotides (lanes 5-10) was able to disrupt either the slower or faster migrating DNA-protein complexes formed between the 32P-labeled Ets consensus oligonucleotide and ovEts-2-GST-fusion protein (lanes 1 and 3). The slight variation in intensities in the faster and slower migrating specific complexes across lanes 5-10 likely resulted from differences in gel loading. EMSA experiments employing labeled oligonucleotides representing the putative Ets-binding sites within the 140 bp promoter failed to provide specific complexes with recombinant Ets-2 (data not shown). Together, these results indicate that Ets-2 is unable to associate with the proximal promoter and that none of the putative Ets-binding sites present is likely to be functional.
###end p 30
###begin title 31
Activation of the Tkdp-1 promoter by C/EBPs in JEG-3 cells
###end title 31
###begin p 32
###xml 139 141 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 206 208 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 209 211 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 225 232 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 299 301 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 342 343 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 389 396 367 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 512 514 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 743 745 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 791 798 757 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 949 950 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
C/EBPs are basic-leucine zipper transcription factors, comprising of six family members (-alpha, -beta, -gamma, -delta, -epsilon and -xi) [29]. C/EBP proteins are known to interact with Ets family members [30-33]. The 140 bp Tkdp-1 promoter possesses a consensus CCAAT/enhancer element (TTATGCAAT) [34] located between -117 and -109 bp (Fig. 3). Accordingly, determined whether the 140 bp Tkdp-1 promoter construct was responsive to over-expression of three C/EBP family members (-alpha, -beta and -delta) (Fig. 8A). None of the three C/EBP family members used here had an effect on the basal promoter activity, and only a slight increase was observed in presence of Ets-2. When Ets-2 was over-expressed in presence of 250 muM 8-Br-cAMP (Fig. 8B) each family member further up-regulated the Tkdp-1 promoter activity, with C/EBP-beta being the most potent. Together, these results suggest that the Ets-2/cAMP/PKA effect on the promoter noted in Fig. 6 is possibly mediated through C/EBP-beta.
###end p 32
###begin title 33
Mutation of the C/EBP binding site in theTkdp-1 minimal promoter reduces its activity
###end title 33
###begin p 34
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1337 1339 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 1511 1518 1500 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
When the CCAAT/enhancer element (TTATGCAAT) of the 140 bp Tkdp-1 promoter-reporter construct was mutated (TTATcCccc) both the basal transcriptional activity and the effects of Ets-2, PKA and Ets-2+PKA were markedly reduced (~90 %) compared to the wild type promoter in JEG-3 cells (Fig. 9A). That the C/EBP-binding site mutation had no additional effect on Ets-2-dependent than on basal promoter activation was somewhat surprising, However, basal promoter activity is quite high in JEG-3 cells, e.g. compared to the non-trophobast cell line, NIH3T3, possibly because of the higher content of endogenous Ets2 and other essential transcription factors present in these trophoblast cells. Accordingly, the effect of the mutation on basal activity may be difficult to distinguish from the effect observed when Ets-2 is expressed ectopically. Reduction in the basal promoter activity and the Ets-2 or Ets-2+Ras responsiveness was also observed in the 3T3 mouse fibroblast cell line when the CCAAT/enhancer element was mutated (Fig. 9B), and, the effect of the mutation when Ets-2 was over-expressed was more pronounced. Thus, mutation of the CCAAT/enhancer element largely eliminated the promoter's ability to respond to Ets-2 and the cAMP/PKA or the Ras/MAPK signal transduction pathways. These data along with our earlier observation (Fig. 8A) that C/EBP-alpha, -beta or -delta has no effect on the reporter gene expression by its own, suggest that the effects of PKA, Ets-2, Ets-2+PKA and Ets-2+Ras on the 140 bp Tkdp-1 promoter are mediated through the C/EBP-binding site, conceivably through a direct interaction of Ets-2 with C/EBP-beta.
###end p 34
###begin title 35
C/EBP-beta directly interacts with theTkdp-1 promoter
###end title 35
###begin p 36
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 150 158 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 378 380 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 1285 1292 1260 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 1108 1114 <span type="species:ncbi:9986">rabbit</span>
In order to identify which of the three C/EBP family members used in the transfection experiments (Fig. 8A and 8B) interacts with the 140 bp promoter in vitro, we performed EMSA with a 32P-labeled double-stranded (ds) oligonucleotide possessing the C/EBP-binding site of the Tkdp-1 promoter, JEG-3 cell extracts, and antibodies specific for C/EBP-alpha, -beta, and -delta (Fig. 10). As shown in lane 1, a specific DNA-protein complex was formed between the CCAAT/enhancer element and JEG-3 cell extracts. Excess unlabeled competitor oligonucleotide containing the wild-type C/EBP-binding site (TTATGCAAT; lane 7) inhibited formation of the specific complex when it was added to the reaction mixture. However, an unlabeled oligonucleotide possessing a mutated C/EBP-binding site (TTATcCccc; lane 8) failed to compete in the binding reaction. The addition of an antiserum directed against individual C/EBPs only provided a major "supershift" when the anti-C/EBP-beta reagent was employed (lane 4). There was a minor effect noted with anti-C/EBP-alpha (lane 3). Neither anti-C/EBP-delta (lane 5) nor non-immune rabbit IgG (lane 6) had any effect. Thus C/EBP-beta would appear to be the major isoform of C/EBP that binds the TTATGCAAT element present in the 140 bp minimal promoter of the Tkdp-1 gene.
###end p 36
###begin title 37
Interaction between C/EBP-beta and Ets-2 in JEG-3 cells
###end title 37
###begin p 38
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 436 439 430 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11A</xref>
###xml 273 279 <span type="species:ncbi:9986">rabbit</span>
###xml 595 601 <span type="species:ncbi:9986">rabbit</span>
Co-immunoprecipitation (Co-IP) and oligonucleotide pull-down experiments were performed to demonstrate the in vivo interaction between C/EBP-beta and Ets-2 in JEG-3 cells. For the former, endogenous Ets-2 in JEG-3 cell extracts was allowed to form an immune complex with a rabbit polyclonal Ets-2-specific immunoglobulin, collected on Protein-A beads and then subjected to western blot analysis with C/EBP-beta-specific antiserum (Fig. 11A, lane 3). The data indicate that endogenous C/EBP-beta is associated with Ets-2 in JEG-3 cell extracts. No C/EBP-beta protein was detected when non-immune rabbit IgG was substituted for the anti-Ets-2 antiserum (lane 4). As positive control, endogenous C/EBP-beta was collected with C/EBP-beta-specific antiserum and the western blot developed with the same antiserum (lane 2).
###end p 38
###begin p 39
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 255 258 252 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11B</xref>
###xml 569 572 560 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11C</xref>
###xml 790 793 781 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11C</xref>
###xml 1044 1045 1032 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
When a streptavidin-bound, biotinylated ds oligonucleotide representing the C/EBP-binding region of the Tkdp-1 promoter was used as a bait to collect proteins present in JEG3 cells, the oligonucleotide was able to trap endogenous C/EBP-beta (lane 3, Fig. 11B). This ability to bind C/EBP-beta was inhibited in the presence of an excess of unlabeled wild type competitor oligonucleotide, but not by unlabeled mutated competitor (lanes 5 versus 4). The C/EBP-binding site containing biotinylated oligonucleotide was able to trap Ets-2 as well as C/EBP-beta (lane 3, Fig. 11C), even though it did not possess a known Ets-binding sequence. The Ets-2-specific bands were not detected when excess unlabeled, wild-type competitor oligonucleotide was included in the reaction mixture (lane 4, Fig. 11C). These data provide conclusive evidence that Ets-2 associates with C/EBP-beta while the latter is bound to its CCAAT-binding-sequence. The possibility that Ets-2 bound to the CCAAT/enhancer element directly is unlikely in view of earlier data (Fig. 7).
###end p 39
###begin title 40
Mutation of the AP-1-binding site does not affect the Ets-2-responsiveness of the Tkdp-1 promoter
###end title 40
###begin p 41
###xml 11 18 11 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12A</xref>
###xml 550 559 550 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 816 823 813 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
The 140 bp Tkdp-1 promoter possesses a conserved AP-1 element (-99 to -93) immediately downstream of the CCAAT/enhancer element (-117 too -109). In order to determine the functional importance of this site for transcriptional activation of the promoter, site-directed mutagenesis followed by transient transfection experiments were performed. As demonstrated in Fig. 12A, mutation of the AP-1 element caused up to 90% reduction in basal activity and 74% reduction in PKA-dependent promoter activation. This mutation did not affect the Ets-2-mediated ovTkdp-1 promoter activation, although it reduced the effect of the Ets-2 plus PKA combination on the promoter by up to 65%. Together these data indicate that the AP-1 element adjacent to the C/EBP-beta-binding site is important in regulating transcription from the Tkdp-1 minimal promoter and for activation of transcription by the cAMP/PKA signaling pathway, but is not involved in the recruitment of Ets-2 to the promoter.
###end p 41
###begin title 42
The AP-1 element in the 140 bpTkdp-1 promoter interacts with C/EBP-beta
###end title 42
###begin p 43
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12B</xref>
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12C</xref>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12C</xref>
###xml 641 644 635 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12B</xref>
Pull-down assays were conducted in JEG-3 extracts with a biotinylated, ds oligonucleotide containing positions -99 to -93 of the Tkdp-1 promoter (Fig. 12B and 12C). Some interactions between this element and several Jun family transcription factors (c-Jun, Jun B, Jun D and p39) could be demonstrated by western blotting (Fig. 12C). By contrast none of the Fos-related proteins (c-Fos, Fos B, Fra-1 and Fra-2) was pulled down from the JEG-3 cell extracts (negative results not shown). Unexpectedly, this AP-1 element-protein complex contained C/EBP-beta, suggesting that whatever bound to this sequence also associated with C/EBP-beta (Fig. 12B).
###end p 43
###begin title 44
Expression of Ets-2 and C/EBP-beta transcripts in conceptuses
###end title 44
###begin p 45
###xml 248 250 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 255 257 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 320 327 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 48 53 <span type="species:ncbi:9940">sheep</span>
RT-PCR analyses performed on RNA extracted from sheep conceptuses/trophoblast at days 14, 15, 16, 17 and 25 of pregnancy showed that C/EBP-beta mRNA, like Ets-2 mRNA, is expressed relatively uniformly over these days of conceptus development (Fig. 1B and 1C). This expression pattern is in sharp contrast to that of the Tkdp-1 gene, whose expression pattern is maximal around day 17 and then tails off by day 25.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 804 805 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 806 808 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 809 811 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 953 955 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 956 958 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 959 961 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1319 1321 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 507 513 <span type="species:ncbi:9913">cattle</span>
###xml 515 520 <span type="species:ncbi:9940">sheep</span>
###xml 522 526 <span type="species:ncbi:9925">goat</span>
TKDP-1 is an abundant secretory product of the ruminant placental trophoblast cells during the peri-implantation stage of pregnancy, a period when the enlarging blastocyst starts to signal its presence to the mother in preparation for establishing an intimate contact with the uterine endometrium [2,7,35]. This stage of conceptus development is also marked by the production of IFN-tau, the protein responsible for "rescue" of the corpus luteum during early pregnancy in ruminant ungulate species, such as cattle, sheep, goat and deer. Like ovTKDP-1, IFN-tau is a product of trophoblast mononuclear cells, and its production rises sharply as the blastocyst expands and begins to elongate, presumably in response to growth factors, hormones and cytokines present in the uterine secretions of the mother [2,11,12]. Many of such factors operate through activation of established signal transduction pathways, including the Ras/MAPK and cAMP/PKA pathways [12,36,37]. Shutdown of expression after the trophoblast begins to adhere to the uterine wall might be due to lack of access of the adherent trophectoderm to these maternal factors, which probably originate from the uterine glands of the underlying endometrium. The striking similarity in the expression patterns of ovTKDP-1 and IFN-tau, which is illustrated in Fig. 1A, led us to speculate that the genes for these two proteins might be controlled by similar transcriptional mechanisms, involving the same transcription factors and signal transduction pathways.
###end p 47
###begin p 48
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 875 879 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG </italic>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1110 1117 1110 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 155 175 <span type="species:ncbi:11946">avian leukemia virus</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 726 732 <span type="species:ncbi:9913">bovine</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
###xml 967 972 <span type="species:ncbi:10090">mouse</span>
The starting point for our study on Tkdp-1 transcriptional control was the Ets family transcription factor, Ets-2, a homolog for the viral oncogene of the avian leukemia virus E26 [38]. Although expressed widely in adult and embryonic tissues, Ets-2 is required for placental development in the mouse [39] and supports expression of several genes, including the IFNT, whose expression provide a phenotypic "signature" for trophectoderm [15-21,23]. The promoters of each of these genes possess functional Ets-2-binding sites which, when mutated, cause almost complete loss of reporter gene expression. Ets-2 transcripts are certainly present in the ovine conceptus (Fig. 1B), and Ets-2 protein is expressed in trophectoderm of bovine conceptuses of equivalent developmental stage [22], but appears to be limiting for driving maximal expression of reporter genes from IFNT and hCG subunit gene promoters in human choriocarcinoma cells, such as JAr and JEG3, and in 3T3 mouse fibroblasts [23]. Our first goal, therefore, was to determine whether Ets-2 might play a role, possibly a central one, in control of the Tkdp-1 gene expression, just as it does in controlling the activities of other signature genes of trophectoderm.
###end p 48
###begin p 49
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 501 508 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG </italic>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1105 1112 1105 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 1146 1174 1146 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT, hCG&#945;, and hCG&#946; </italic>
###xml 1185 1187 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1188 1190 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1191 1193 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1194 1196 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1264 1271 1257 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 1412 1420 1405 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG&#945;</italic>
###xml 1422 1429 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG&#946;</italic>
###xml 1435 1440 1421 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 1447 1449 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1450 1452 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1453 1455 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 854 859 <span type="species:ncbi:9606">human</span>
Based on the fact that the Tkdp-1 promoter possessed several sites that might bind Ets-2 or one of its relatives, transient transfection experiments were performed in JEG3 choriocarcinoma cells to test the effects of various Ets family transcription factors on the Tkdp-1 promoter expression (Fig. 4A). As expected, Ets-2 proved most effective of the factors tested and up-regulated the Tkdp-1 promoter about as well as it did the IFNT promoter [12]. The ability of Ets-2 to drive expression from the Tkdp-1 promoter in 3T3 cells required an activated MAPK pathway (Fig. 5) and was at least partially dependent on the MAPK target residue, Thr 72, in the so-called "pointed" domain of the protein[23]. These results were entirely consistent with Ets-2 effects on the IFNT and hCG subunit gene promoters when they were examined in 3T3 cells [16,23,28]. In human choriocarcinoma cells, expression was highly responsive to over-expression of the catalytic subunit of PKA. A combination of PKA and Ets-2 over-expression could up-regulate the promoter over 700-fold (Fig. 6A). Again, in all these respects, the Tkdp-1 promoter behaved similarly to the IFNT, hCGalpha, and hCGbeta promoters [11,16,17,23]. Finally, we have also demonstrated that the Ets-2 effects on the Tkdp-1 promoter are silenced by the expression of Oct-4 (Chakrabarty, A. and Roberts, R. M., unpublished results), another feature shared with the, hCGalpha, hCGbeta, and IFNT genes [29,40,41]. These similarities suggest that all these trophoblast-expressed genes share a common transcriptional control mechanism, with a central role played by Ets-2 in each, which allows the genes to be up-regulated soon after the trophectoderm cell lineage first emerges.
###end p 49
###begin p 50
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT</italic>
###xml 25 34 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG&#945; </italic>
###xml 38 46 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hCG&#946; </italic>
###xml 249 251 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 252 254 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 255 257 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 258 260 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 261 263 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 299 306 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 353 356 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp</italic>
###xml 393 394 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 399 401 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 474 483 467 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 489 490 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 704 711 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 787 792 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
In the case of the IFNT, hCGalpha and hCGbeta genes, however, transactivation by Ets-2 is entirely dependent upon the ability of the transcription factor to bind directly to DNA at recognizable, although relatively diverse, Ets-2-binding sequences [11,16,17,23,42]. Strikingly, the proximal/minimal Tkdp-1 promoter region between 82 and 140 bp from the tsp, which is responsive to Ets-2 (Fig. 2 and 4B), seems physically incapable of forming a stable association with Ets-2 in vitro (Fig. 7). The most obvious conclusion is that Ets-2 must form an association with a second transcription factor that binds within this critical region, and, when so positioned, is able to influence transcription from the Tkdp-1 gene promoter about as efficiently as it does when it binds directly to the IFNT promoter.
###end p 50
###begin p 51
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp </italic>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 371 378 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 461 463 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 622 624 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 668 673 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNT </italic>
###xml 1010 1012 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1144 1146 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1147 1149 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1150 1152 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1153 1155 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1257 1259 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1260 1262 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1473 1475 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1476 1478 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1636 1638 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1639 1641 1602 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 438 443 <span type="species:ncbi:9606">human</span>
###xml 1123 1126 <span type="species:ncbi:9860">Elk</span>
The next goal, therefore, was to elucidate the mechanism by which Ets-2 controls Tkdp-1 gene expression without a direct interaction with the DNA. Our initial focus was on a conserved CCAAT/enhancer element located between 117 and 109 bp up-stream of the tsp (Fig. 3). There are several reasons to consider the possibility that a CCAAT-binding protein might regulate the Tkdp-1 gene. First, C/EBP-alpha, -beta and -delta are expressed in human placental cells [29]. Second, C/EBP-beta transactivates multiple genes that are expressed by trophoblast cells, including the gene for the homeobox protein distal-less-3 (Dlx3) [43], a transcription factor that binds to the IFNT promoter and co-operatively enhances its Ets-2 responsiveness (Ezashi, T. and Roberts, R. M.; unpublished data). Third, recent experiments have suggested a crucial role for C/EBP-alpha and -beta in embryogenesis, since deletion of both genes results in mortality around embryonic day 10-11 due to gross failure in placental development [44]. Fourth, C/EBP-alpha and -beta have been demonstrated to interact with several Ets family members, including Elk-1, Fli-1, Ets-1 [30,32,33,45]. Fifth, C/EBP proteins, particularly C/EBP-beta, are responsive to both cAMP/PKA and MAPK pathways [34,46]. Activation of the cAMP/PKA pathway promotes C/EBP-beta gene transcription, nuclear translocation, recruitment of transcriptional co-activators (e.g. CBP/p300) and phosphorylation at specific serine residues [46-55], while the major effect of the MAPK pathway on C/EBP-beta is mediated through phosphorylation at specific threonine residues, which leads to its activation[55,56].
###end p 51
###begin p 52
###xml 117 124 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 169 171 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 405 407 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 477 484 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 723 725 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 730 732 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
When over-expressed in JEG-3 cells, none of the C/EBP isoforms -alpha, -beta, and -delta had an effect on the 140 bp Tkdp-1 minimal promoter. In presence of Ets-2 (Fig. 8A), a modest increase in promoter activity was observed. When Ets-2+C/EBP-beta-transfected cells were treated with 250 muM Br-cAMP, a synergistic increase in promoter activity was observed, particularly in presence of C/EBP-beta (Fig. 8B). Thus, in JEG-3 cells, maximal effects of the C/EBP proteins on the Tkdp-1 promoter require the participation of both Ets-2 and the cAMP/PKA signaling pathway. Transient transfection experiments and EMSA indicated C/EBP-beta was the most potent of the C/EBP isoforms that bound to the CCAAT/enhancer element (Fig. 8A and 8B).
###end p 52
###begin p 53
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 335 337 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 592 599 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 754 756 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 876 882 867 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11A, B</xref>
###xml 887 890 878 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11C</xref>
###xml 959 966 947 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 1218 1226 1203 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1294 1303 1276 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
Further importance of the CCAAT/enhancer element in controlling transcriptional activity of the 140 bp Tkdp-1 promoter was demonstrated by mutational analysis (Fig. 9A and 9B). Not only was an intact CCAAT element required for C/EBP-beta binding and basal promoter activity, but also for Ets-2- and Ets-2+PKA-mediated activation (Fig. 9A). Thus, C/EBP-beta bound to the CCAAT/enhancer element is likely to be the target for the cAMP/PKA signaling pathway and also responsible for recruiting Ets-2. Further support for the importance of C/EBP-binding site in Ets-2-dependent activation of the Tkdp-1 promoter came from co-transfection experiments in NIH3T3 cells, where the mutated promoter demonstrated markedly reduced Ets-2 and Ets-2+Ras effects (Fig. 9B). Co-IP and pull-down assays confirmed a direct association between C/EBP-beta and Ets-2 proteins in JEG-3 cells (Fig. 11A, B and 11C). Together, these experiments indicate that C/EBP-beta binds to the Tkdp-1 promoter between -117 and -109 and that Ets-2 is recruited to this site via protein-protein interaction with C/EBP-beta. It should be noted here that due to the unavailability of an appropriate ovine trophoblast cell line, further demonstration of the in vivo association between C/EBP-beta and Ets-2 proteins in context of the ovTkdp-1 promoter using the chromatin immunoprecipitation assay was not possible.
###end p 53
###begin p 54
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 404 411 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 585 588 585 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12A</xref>
###xml 639 646 639 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 927 930 927 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12C</xref>
###xml 1005 1008 1002 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F12">12B</xref>
###xml 1077 1079 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1135 1137 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1224 1231 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
Our next focus was on a putative AP-1 element at -99 to -93, adjacent to the CCAAT/enhancer motif in the Tkdp-1 promoter (Fig. 3), since AP-1 family transcription factors, especially c-Jun and c-Fos are known to interact with both Ets and C/EBP proteins [49,57-61]. As shown by site-directed mutagenesis and transfection experiments, this AP-1 site appeared crucial for maintaining basal activity of the Tkdp-1 promoter in JEG-3 cells, as well as for the full PKA responsiveness of the promoter. On the other hand, mutation of the AP-1 site had no effect on Ets-2 responsiveness (Fig. 12A). In other words, PKA-dependent activation of the Tkdp-1 promoter may be mediated by some factor bound to the AP-1 site adjacent to the CCAAT/enhancer motif. Pull down experiments with a broad spectrum antibody that recognizes multiple members of the Jun family demonstrated that some of these proteins did indeed bind to this site (Fig. 12C). However, C/EBP-beta itself was also a part of the protein complex (Fig. 12B). Since C/EBP proteins bind to DNA as either homo- or heterodimers [62], and C/EBP-beta is known to form complexes with c-Jun[63], it is tempting to speculate that the AP-1 site adjacent to the CCAAT element in the Tkdp-1 promoter recruits a heterodimer consisting of C/EBP-beta and a member of the Jun family of proteins.
###end p 54
###begin p 55
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 586 588 586 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K </italic>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 36 42 <span type="species:ncbi:9913">bovine</span>
###xml 114 120 <span type="species:ncbi:9913">bovine</span>
###xml 278 284 <span type="species:ncbi:9913">bovine</span>
###xml 482 488 <span type="species:ncbi:9913">bovine</span>
###xml 938 944 <span type="species:ncbi:9913">cattle</span>
###xml 949 954 <span type="species:ncbi:9940">sheep</span>
A search of the recent draft of the bovine genome sequence (see website) [64] allowed us to identify the putative bovine ortholog of the Tkdp-1 gene (between positions 424335-407548 on contig no. NW_928686 on chromosome 13). There is 89% sequence identity between the ovine and bovine genes over the 140 bp region directly upstream of the transcription start site determined for the ovine gene (Additional data file 1 - Fig. 3). The single base mutation in the CCAAT element in the bovine gene (TTAcGCAAT versus TTATGCAAT) would likely not destroy the core C/EBP-binding motif (TKNNGNAAK ; where K = T or G and N = any nucleotide) [65], while the single base mutation in the AP-1-binding site (TGACcCA versus TGACTCA) might well reduce its ability to interact with typical AP-1 proteins. The high degree of conservation in the C/EBP-beta binding sequence maintained over the 17 million or so years since the lineage leading to modern day cattle and sheep diverged provides an additional argument for the importance of the CCAAT motif.
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
The pattern of expression of the ovine trophoblast Kunitz domain protein-1 produced by the trophectoderm during the peri-implantation stage of embryo development is almost identical to that of IFN-tau and directed by the same transcription factor, Ets-2, in combination with the protein kinase A and mitogen-activated protein kinase signal transduction pathways, but does not involve direct binding of Ets-2 to promoter control elements. Instead, up-regulation of the gene is accomplished indirectly through protein-protein interactions with C/EBP-beta. Most importantly, the work reported here demonstrates how Ets-2, a key transcription factor for trophoblast differentiation and function, can control expression of genes having similar spatial and temporal expression patterns via very different mechanisms.
###end p 57
###begin title 58
Methods
###end title 58
###begin title 59
###xml 69 74 <span type="species:ncbi:9940">sheep</span>
Reverse transcription polymerase chain reaction (RT-PCR) analyses of sheep conceptus RNA
###end title 59
###begin p 60
###xml 466 468 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 617 619 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 855 856 846 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 300 305 <span type="species:ncbi:9940">sheep</span>
Animal husbandry and surgical procedures were performed according to the protocols approved by the Animal Care and Use Committee at the University of Missouri-Columbia [66, 3097]. Expression patterns of TKDP-1, IFN-tau, Ets-2, C/EBP-beta, and ribosomal protein S25 mRNAs were determined by RT-PCR on sheep conceptus/ trophoblast RNA collected on days 14, 15, 16, 17, 19 and 25 of pregnancy. RNA was extracted by using RNA STAT-60 reagent (Tel-Test, Friendswood, TX)[66]. RT reactions were performed on 1-2 mug RNA (pre-treated with deoxyribonuclease; Ambion, Inc., Austin, TX) by using Super-Script III ribonuclease H- reverse transcriptase (Invitrogen, Carlsbad, CA) in presence of 50 muM oligodeoxythymidine (dT) primer. RT reaction product (5 mul) was used for each 50 mul PCR reaction with 100 ng of sense and anti-sense primers (Additional data file 1 - Table 1) and PicoMaxx High Fidelity PCR Master Mix (Stratagene, La Jolla, CA). Twenty-five PCR cycles were used to amplify TKDP-1, IFN-tau and S25 messages, while 30-35 cycles were needed to visualize the Ets-2 and C/EBP-beta-mRNAs. PCR products were resolved through 1.5% TAE (Tris-acetate-EDTA)-agarose gels at 100 volts for 1 h and stained with ethidium bromide. In order to confirm that RNA preparations were free of DNA, control RT reactions were performed without initial reverse transcription. As positive controls we employed 10 ng plasmid DNAs encoding the open reading frames for ovTKDP-1, ovIFN-tau4, Ets-2, C/EBP-beta and ribosomal protein S25.
###end p 60
###begin title 61
Constructs, antibodies and cell culture reagents
###end title 61
###begin p 62
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp</italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 198 200 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/ </sup>
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(UTR) </italic>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 332 334 332 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/ </sup>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UTR </italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1324 1325 1310 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1705 1707 1691 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1739 1741 1725 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1980 1999 1955 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-galactosidase </italic>
###xml 799 806 <span type="species:ncbi:9031">chicken</span>
###xml 814 819 <span type="species:ncbi:9606">human</span>
###xml 827 832 <span type="species:ncbi:10090">mouse</span>
###xml 840 845 <span type="species:ncbi:9606">human</span>
###xml 853 858 <span type="species:ncbi:10090">mouse</span>
###xml 866 871 <span type="species:ncbi:10090">mouse</span>
###xml 981 986 <span type="species:ncbi:10090">mouse</span>
###xml 1835 1838 <span type="species:ncbi:10116">rat</span>
###xml 1852 1857 <span type="species:ncbi:10090">mouse</span>
###xml 1873 1878 <span type="species:ncbi:10090">mouse</span>
###xml 2184 2199 <span type="species:ncbi:10633">Simian virus 40</span>
###xml 2227 2231 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The transcription start point (tsp) of the Tkdp-1 gene [Genbank:] is located at ~35 bp downstream of a putative TATA-like sequence (1730 in the Tkdp-1 gene) within the 1 Kbp region upstream of the 5/ untranslated region (UTR) [2]. Chimeric promoter-reporter plasmids were constructed by amplifying the 1 Kbp region upstream of the 5/ UTR by PCR to generate 1000 bp, 558 bp, 352 bp, 254 bp, 192 bp, 140 bp and 82 bp fragments. After verifying their sequences, these products were inserted between the HindIII and XhoI restriction sites on the pGL2 Basic promoter-less plasmid containing the Luc reporter gene (Promega, Madison, WI). Additional data file 1 - Table 2 lists all sense primers used in combination with a common anti-sense primer for generating the PCR fragments. Expression plasmids for chicken Ets-1, human Ets-2, mouse Elf-1, human Fli-1, mouse PEA-3, mouse PU.1 were provided by Dr. Michael Ostrowski, Ohio State University, Columbus, OH. The expression vectors for mouse GABP-alpha and -beta1 were from Dr. M. E. Martin, University of Missouri, Columbia, MO. The GABP-alpha and -beta1 plasmids were used together, as GABP functions as a heterodimer. The mutated Ets-2 construct (pCGNEts-2A72) and constitutively active Rasexpression vector pHO6T1 or its parental vector Homer6 have been described elsewhere [2]. The plasmid used to express the constitutively active form of the catalytic subunit of PKA expression construct was a generous gift from Dr. Mark S. Roberson, Cornell University College of Veterinary Medicine, Ithaca, NY. The plasmids for the catalytically inactive PKA expression construct (mutPKA), in which the ATP-binding codon, lysine 72, had been mutated to methionine; [23], and the PKA inhibitor, PKI, [67] were provided by Dr. Richard A. Maurer, University of Iowa, Iowa City, Iowa. Constructs for rat C/EBP-alpha, mouse C/EBP-beta and mouse C/EBP-delta were obtained from Dr. Steven L. McKnight (Southwestern Medical School, Dallas, TX). The beta-galactosidase gene driven by the Rouse sarcoma virus LTR (pRSVLTR-beta-gal) was provided by Dr. R. V. Guntaka, University of Missouri, Columbia, MO. The Renilla-Luciferase reporter plasmid driven by Simian virus 40 enhancer and promoter (pRL-SV40) was purchased from Promega (Madison, WI).
###end p 62
###begin p 63
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
The CCAAT/enhancer element between -117 and -109 and the AP-1 element between -99 and -93 of the Tkdp-1 promoter were mutated by using the Quik Change Site-directed Mutagenesis kit from Stratagene (La Jolla, CA). Sequences of the sense and anti-sense primers are listed in additional data file 1 - Table 3. The fidelity of mutation was checked by sequencing with the pGL2 Basic vector-specific GL-1 and GL-2 primers (Promega, Madison, WI).
###end p 63
###begin p 64
###xml 64 69 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-61</italic>
###xml 79 85 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-150</italic>
###xml 96 102 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-151</italic>
###xml 112 115 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-</italic>
###xml 130 135 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-44</italic>
###xml 184 190 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-413</italic>
###xml 258 265 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sc-2027</italic>
###xml 18 24 <span type="species:ncbi:9986">rabbit</span>
###xml 246 252 <span type="species:ncbi:9986">rabbit</span>
Affinity purified rabbit polyclonal antibodies for C/EBP-alpha (sc-61), -beta (sc-150), -delta (sc-151), Ets-2 (sc-351), pan-Jun (sc-44; recognizes c-Jun, Jun B, Jun D, p39), pan-Fos (sc-413; recognizes c-Fos, Fos B, Fra-1, Fra-2) and non-immune rabbit IgG (sc-2027) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
###end p 64
###begin p 65
###xml 6 12 <span type="species:ncbi:9913">bovine</span>
Fetal bovine serum was purchased from Harlan (Indianapolis, IN). Media for mammalian cell culture (MEM and DMEM), cell culture-grade sodium pyruvate, L-glutamine and penicillin-streptomycin solutions were purchased from Invitrogen (Carlsbad, CA). Peptidase and phosphatase inhibitors, 8-bromo-cAMP (8-Br-cAMP), and MEM non-essential amino acid solution were purchased from Sigma (Saint Louis, MO).
###end p 65
###begin title 66
Cell culture, transfection and statistical analyses
###end title 66
###begin p 67
###xml 242 244 242 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 699 701 692 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 743 745 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 355 361 <span type="species:ncbi:9913">bovine</span>
Transfection experiments were performed in either the human choriocarcinoma JEG-3 cells or the mouse fibroblast NIH3T3 cells (for experiments with activated Ras). Both cell lines were purchased from ATCC (Manassas, VA) and maintained in 5% CO2 in air and at 37degreesC in media (MEM for JEG-3 and DMEM for 3T3 cells) containing 10% heat-inactivated fetal bovine serum and 50 U/ml penicillin and 50 mug/ml streptomycin. Medium for JEG-3 cells was supplemented with 1 mM sodium pyruvate and 1x non-essential amino acid. DMEM for 3T3 cells was supplemented with 4 mM L-glutamine. The day before transfection, cells were plated in 60 mm (JEG-3 cells) or 35 mm dishes (3T3 cells) at a density of 2.5 x 105 cells/60 mm dish (JEG-3 cells) or 1.7 x 105 cells/35 mm dish (3T3 cells).
###end p 67
###begin p 68
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 474 478 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 617 621 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 923 927 912 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 1064 1068 1050 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 1077 1081 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 282 286 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Transient transfection experiments (repeated at least twice in triplicate) in JEG-3 and NIH3T3 cells were performed with calcium phosphate [68] and FuGene 6 reagents (Roche Molecular Biochemicals, Indianapolis, IN), respectively. The pRSVLTR-beta-gal (0.025 mug/60 mm dish) and pRL-SV40 (0.008 mug/35 mm dish) constructs were used as internal normalization controls in JEG-3 and 3T3 cells, respectively. Each set of transfections in 60 mm dish was performed with 3.5 mug of Luc reporter construct and 0.5 mug of the plasmid DNA for each transcription factor. Cells in each 35 mm dish were transfected with 1.7 mug of Luc construct, 0.25 mug Ets-2 or PKA expression construct and 0.6 mug activated Ras expression construct. Total amount of DNA was kept constant in all transfections by including appropriate empty vector. In some experiments, cells were treated with 250 muM 8-Br-cAMP approximately 10 h after transfection. Luc and beta-galactosidase enzyme assays were usually performed on cell lysates 44-48 h after transfection with commercially available kits (Luc and Dual Luc Assays system from Promega, Madison, WI and Galactolight Plus systems from Applied Biosystems, Foster City, CA) as 15 sec light outputs from a Turner Designs model 20e luminometer (Sunnyvale, CA).
###end p 68
###begin p 69
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 140 144 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
Transfection results were expressed as average fold induction in Luc reporter activity +/- SEM. Statistical test on differences in relative Luc activities (normalized values) were performed by one way ANOVA followed by Tukey's multiple comparison tests (GraphPad Prism version 4).
###end p 69
###begin title 70
Electrophoretic mobility shift assay (EMSA)
###end title 70
###begin p 71
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 156 158 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 389 396 388 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 438 439 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 448 452 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp </italic>
###xml 674 676 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
EMSA was carried out with 32P-labeled ds Ets-2 oligonucleotides (35 fmole) [69] (Additional data file 1 - Table 4) and 2 mug of ovEts-2-GST fusion protein [21] (with GST as control). Competition was provided by addition of either a 250-fold molar excess of unlabeled Ets-2 consensus oligonucleotide or each of six overlapping oligonucleotides spanning the -150 bp to + 20 bp region on the Tkdp-1 promoter (Table 4 in additional data file 1 - data; tsp = +1). Competitor oligonucleotides were added prior to the addition of the labeled oligonucleotide to the binding reaction mixtures. Procedures for DNA binding reactions and electrophoresis have been described previously [23]. The specificity of Ets-2 binding was verified by the ability of 0.3 mug of Ets-2 antibody to retard the DNA-protein complex during electrophoresis.
###end p 71
###begin p 72
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 504 505 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 649 656 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 691 697 <span type="species:ncbi:9986">rabbit</span>
EMSA was also performed with the labeled, ds CCAAT/enhancer element consensus sequence (35 fmol) from the Tkdp-1 gene (between -117 and -109) and 10 mug of JEG-3 cell extracts prepared with 200 mM (pH 7.8) sodium phosphate buffer, 0.5% triton X-100, 0.5 mM dithiothreitol and 1x peptidase inhibitor cocktail (Sigma, St. Louis, MO). The specificity of DNA-protein complex formation was verified by adding 250-fold molar excess of unlabeled wild type or mutated C/EBP oligonucleotide (Additional data file 1 - Table 4). In order to identify which of the three C/EBP isoforms among -alpha, -beta and -delta bound to the CCAAT/enhancer element from the Tkdp-1 gene, 0.4 mug of affinity purified rabbit polyclonal antibody specific to each these transcription factors was added to each reaction.
###end p 72
###begin title 73
Co-immunoprecipitation reactions (Co-IP)
###end title 73
###begin p 74
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
###xml 399 405 <span type="species:ncbi:9986">rabbit</span>
###xml 422 428 <span type="species:ncbi:9986">rabbit</span>
###xml 464 470 <span type="species:ncbi:9986">rabbit</span>
###xml 764 770 <span type="species:ncbi:9986">rabbit</span>
###xml 971 982 <span type="species:ncbi:3704">horseradish</span>
###xml 1016 1022 <span type="species:ncbi:9986">rabbit</span>
Rabbit IgG TrueBlot kit (eBioscience, Inc., San Diego, CA) was used forCo-IP experiments with JEG-3 cells treated with 250 muM 8-Br-cAMP for 24 h prior to cell lysis. Cell extracts were prepared with 200 mM (pH 7.8) sodium phosphate buffer, 0.5% triton X-100, 0.5 mM dithiothreitol and 1x each of the peptidase and phosphatase inhibitor cocktails. For immunoprecipitation (IP), 3 mug of each of the rabbit Ets-2 antibody, rabbit C/EBP-beta antibody and non-immune rabbit IgG were used per mg of protein in cell extracts. Immunoprecipitated samples were resolved through 10% SDS-PAGE under denaturing conditions and protein bands were transferred onto PVDF membranes (Immobilon-P by Millipore Billerica, MA). Western blotting was performed with a 1:500 dilution of rabbit polyclonal C/EBP-beta antibody in blocking solution (25 mM Tris-HCl, pH 7.3, 150 mM NaCl, 0.1% tween-20 and 5% non-fat dry milk). Following incubation with primary antibody, the blot was treated with horseradish peroxidase (HRP) conjugated anti-rabbit IgG (eBioscience, San Diego, CA) at 1:1000 dilution in blocking solution. Membranes were developed with the Phototype-HRP Western Blot Detection System from Cell Signaling Technology, Inc., Beverly, MA, and recorded on Kodak BioMax Light Film (Kodak, Rochester, NY) according to the manufacturers' instructions.
###end p 74
###begin title 75
Pull-down assays
###end title 75
###begin p 76
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/ </sup>
###xml 1110 1116 <span type="species:ncbi:9986">rabbit</span>
Pull-down assays from JEG-3 cell extracts were performed with biotinylated ds oligonucleotides representing C/EBP and AP-1-binding elements (Additional data file 1 - Table 5). Each pair of sense and anti-sense oligonucleotides was prepared and modified (3/ biotinylation of the sense strand) by MWG-Biotech (High Point, NC). Biotinylated ds oligonucleotide were incubated with 50 mul of immobilized streptavidin (Pierce Biotechnology, Rockford, IL) at 4degreesC for 1-2 h, followed by addition of 0.5 to 1.0 mg of JEG-3 cell extracts (prepared with 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 0.5 mM dithiothreitol and 1x each of the peptidase and phosphatase inhibitor cocktails (Sigma, Saint Louis, MO) at 4degreesC for overnight with gentle mixing. The immobilized DNA-protein complex was washed (3x) with cold 25 mM Tris-HCl, pH 7.5, 150 mM NaCl and boiled with 5x SDS-loading dye under denaturing condition and resolved through 10% SDS-PAGE gels. Proteins were transferred from the gel to the PVDF membrane as described above. Western blotting was performed with 1:750 dilution of each of the rabbit polyclonal Ets-2, C/EBP-beta, pan-Jun and pan-Fos antibodies and developed by the Western-Star Systems from Applied Biosystems (Bedford, MA) according to the manufacturer's instruction.
###end p 76
###begin title 77
Supplementary Material
###end title 77
###begin title 78
Additional data file 1
###end title 78
###begin p 79
###xml 224 233 219 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 322 331 317 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 522 531 517 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 609 618 604 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 627 631 622 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 672 681 667 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 716 722 <span type="species:ncbi:9913">bovine</span>
The additional data file 1 consists of tables of sense and anti-sense primers used for RT-PCR amplification of ovTKDP-1, IFN-tau, ribosomal protein S25, Ets-2 and C/EBP-beta messages, oligonucleotides for PCR-cloning of the ovTkdp-1 promoter constructs, site-directed mutagenesis of the C/EBP and AP-1 sites in the 140 bp ovTkdp-1 promoter, sense oligonucleotides used for EMSA and sense and anti-sense oligonucleotides used for biotinylated pull-down assays. It also contains figures of putative Ets-binding sites in the ovTkdp-1 promoter, effect of 8-Br-cAMP on the Ets-2-mediated activation of the 1000 bp ovTkdp-1 promoter-Luc reporter construct and comparison of the ovTkdp-1 minimal promoter with its putative bovine ortholog.
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Acknowledgements
###end title 81
###begin p 82
AC participated in the experimental design, carried out all the experiments and data analysis, helped to prepare the initial draft of this manuscript. RMR contributed to the conceptual basis of this study, directed AC in this work as part of her Ph.D. dissertation, and prepared the final draft of this manuscript. This research was supported by the NIH Grants R01 HD21896 and R01 HD42201 to RMR. Both authors approved the manuscript. The authors have no competing interests.
###end p 82
###begin p 83
The authors thank Drs. T. Ezashi and G. Chowdhury (University of Missouri, Columbia) for their critical suggestions and Angela M. Walker for her technical assistance in this research. We extend our appreciation to Drs. R. V. Guntaka, M. E. Martin (University of Missouri, Columbia), M. C. Ostrowski (Ohio State University, Columbus), M. S. Roberson (Cornell University College of Veterinary Medicine, Ithaca), R. A. Maurer (University of Iowa, Iowa City) and S. L. McKnight (Southwestern Medical School, Dallas) for providing us with constructs for transfection experiments and Norma McCormack for preparing the manuscript and figures for submission.
###end p 83
###begin article-title 84
Origin and evolution of the TKDP gene family
###end article-title 84
###begin article-title 85
###xml 107 113 <span type="species:ncbi:9913">cattle</span>
###xml 118 123 <span type="species:ncbi:9940">sheep</span>
Family of Kunitz proteins from trophoblast: expression of the trophoblast Kunitz domain proteins (TKDP) in cattle and sheep
###end article-title 85
###begin article-title 86
Structure of beta 2-bungarotoxin: potassium channel binding by Kunitz modules and targeted phospholipase action
###end article-title 86
###begin article-title 87
Twenty Years of Dendrotoxins
###end article-title 87
###begin article-title 88
Calcicludine, a Venom Peptide of the Kunitz-type Protease Inhibitor Family, is a Potent blocker of high-threshold Ca+2 Channels with a High-affinity for L-type channels in cerebellar Granule Neurons
###end article-title 88
###begin article-title 89
###xml 4 10 <span type="species:ncbi:9913">bovine</span>
The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein
###end article-title 89
###begin article-title 90
###xml 152 157 <span type="species:ncbi:9940">sheep</span>
Selective cloning of cDNA for secretory proteins of early embryos. Identification of a transiently expressed kunitz domain protein from preimplantation sheep trophoblast
###end article-title 90
###begin article-title 91
Atypical Kunitz-Type Serine Proteinase Inhibitors Produced by the Ruminant Placenta
###end article-title 91
###begin article-title 92
Interferons as hormones of pregnancy
###end article-title 92
###begin article-title 93
###xml 99 104 <span type="species:ncbi:9940">sheep</span>
Antiluteolytic effects of blatstocyst-secreted interferon investigated in vitro and in vivo in the sheep
###end article-title 93
###begin article-title 94
Regulation of Interferon-{tau} (IFN-{tau}) Gene Promoters by Growth Factors that Target the Ets-2 Composite Enhancer: A Possible Model for Maternal Control of IFN-{tau} Production by the Conceptus during Early Pregnancy
###end article-title 94
###begin article-title 95
Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression
###end article-title 95
###begin article-title 96
Ets target genes: past, present and future
###end article-title 96
###begin article-title 97
The ETS-domain transcription factor family
###end article-title 97
###begin article-title 98
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Defective trophoblast function in mice with a targeted mutation of Ets2
###end article-title 98
###begin article-title 99
###xml 119 124 <span type="species:ncbi:9606">Human</span>
A Central Role for Ets-2 in the Transcriptional Regulation and Cyclic Adenosine 5'-Monophosphate Responsiveness of the Human Chorionic Gonadotropin-{beta} Subunit Gene
###end article-title 99
###begin article-title 100
###xml 100 105 <span type="species:ncbi:9606">human</span>
Coordinate regulation of basal and cyclic 5'-adenosine monophosphate (cAMP)-activated expression of human chorionic gonadotropin-alpha by Ets-2 and cAMP-responsive element binding protein
###end article-title 100
###begin article-title 101
###xml 45 50 <span type="species:ncbi:9606">human</span>
Role of Ets2 in cyclic AMP regulation of the human chorionic gonadotropin beta promoter
###end article-title 101
###begin article-title 102
Transcriptional activation of the decidual/trophoblast prolactin-related protein gene
###end article-title 102
###begin article-title 103
Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways
###end article-title 103
###begin article-title 104
Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor
###end article-title 104
###begin article-title 105
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Identification of a placental-specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP-1 (activator protein 1) families of transcription factors
###end article-title 105
###begin article-title 106
Control of interferon-tau gene expression by Ets-2
###end article-title 106
###begin article-title 107
Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c- fms signaling
###end article-title 107
###begin article-title 108
Phosphorylation of the ETS-2 protein: Regulation by the T-cell antigen receptor-CD3 complex
###end article-title 108
###begin article-title 109
Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1
###end article-title 109
###begin article-title 110
###xml 130 134 <span type="species:ncbi:10090">mice</span>
ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice
###end article-title 110
###begin article-title 111
Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2
###end article-title 111
###begin article-title 112
Protein Kinase A acts synergistically with Ets-2 to transactivate interferon-t gene promoter activity over 500-fold
###end article-title 112
###begin article-title 113
###xml 14 17 <span type="species:ncbi:9860">Elk</span>
C/EBPBeta and Elk-1 synergistically transactivate the c-fos serum response element
###end article-title 113
###begin article-title 114
Biological role of the CCAAT/enhancer-binding protein family of transcription factors
###end article-title 114
###begin article-title 115
Regulation of the cfos serum response element by C/EBPbeta
###end article-title 115
###begin article-title 116
NF-IL6 (C/EBPbeta) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether
###end article-title 116
###begin article-title 117
Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1
###end article-title 117
###begin article-title 118
DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family
###end article-title 118
###begin article-title 119
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Forskolin potentiates G-CSF-induced proliferation of a murine myeloblastic leukemia cell line
###end article-title 119
###begin article-title 120
IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities
###end article-title 120
###begin article-title 121
Activation of the protein kinase A signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants
###end article-title 121
###begin article-title 122
###xml 71 76 <span type="species:ncbi:9606">human</span>
Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene
###end article-title 122
###begin article-title 123
###xml 47 52 <span type="species:ncbi:9606">human</span>
Silencing of the gene for the alpha-subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4
###end article-title 123
###begin article-title 124
Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4
###end article-title 124
###begin article-title 125
###xml 46 51 <span type="species:ncbi:9606">human</span>
Silencing of the gene for the beta subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4
###end article-title 125
###begin article-title 126
###xml 97 102 <span type="species:ncbi:9606">human</span>
Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-a, C/EBP-beta and C/EBP-d in the human placenta
###end article-title 126
###begin article-title 127
A Role for CCAAT/Enhancer-Binding Protein {beta} in the Basal Regulation of the Distal-Less 3 Gene Promoter in Placental Cells
###end article-title 127
###begin article-title 128
Essential requirement of CCAAT/enhancer binding proteins in embryogenesis
###end article-title 128
###begin article-title 129
CCAAT/enhancer-binding proteins: structure, function and regulation
###end article-title 129
###begin article-title 130
Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta
###end article-title 130
###begin article-title 131
Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis
###end article-title 131
###begin article-title 132
ERK1 and ERK2 activate CCAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-g
###end article-title 132
###begin article-title 133
CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation
###end article-title 133
###begin article-title 134
Interaction and functional collaboration of p300 and C/EBPbeta
###end article-title 134
###begin article-title 135
Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBPbeta) transcription
###end article-title 135
###begin article-title 136
CREB controls LAP/C/EBP-beta transcription
###end article-title 136
###begin article-title 137
The role of C/EBP in nutrient and hormonal regulation of gene expression
###end article-title 137
###begin article-title 138
Interferon-g induces C/EBPbeta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells
###end article-title 138
###begin article-title 139
Dual regulation of phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional activation and DNA binding in response to growth hormone
###end article-title 139
###begin article-title 140
The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner
###end article-title 140
###begin article-title 141
###xml 40 43 <span type="species:ncbi:10116">rat</span>
C/EBP binding activity to site F of the rat GLUT2 glucose transporter gene promoter is attenuated by c-Jun in vitro
###end article-title 141
###begin article-title 142
Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPa DNA binding via leucine zipper domain interaction
###end article-title 142
###begin article-title 143
Downregulation of c-Jun expression by transcription factor C/EBPa is critical for granulocytic lineage commitment
###end article-title 143
###begin article-title 144
Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun
###end article-title 144
###begin article-title 145
The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation
###end article-title 145
###begin article-title 146
###xml 30 33 <span type="species:ncbi:10116">rat</span>
The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite
###end article-title 146
###begin article-title 147
###xml 6 9 <span type="species:ncbi:9913">Cow</span>
Blast Cow Sequences
###end article-title 147
###begin article-title 148
Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region
###end article-title 148
###begin article-title 149
###xml 115 118 <span type="species:ncbi:10116">rat</span>
Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver
###end article-title 149
###begin article-title 150
Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene
###end article-title 150
###begin article-title 151
A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription
###end article-title 151
###begin title 152
Figures and Tables
###end title 152
###begin p 153
###xml 0 80 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detection of ovTKDP-1, IFN-&#964;, Ets-2 and C/EBP-&#946; mRNA in sheep trophectoderm</bold>
###xml 312 315 307 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 592 595 583 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 811 814 802 805 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 61 66 <span type="species:ncbi:9940">sheep</span>
###xml 113 118 <span type="species:ncbi:9940">sheep</span>
###xml 568 573 <span type="species:ncbi:9940">sheep</span>
Detection of ovTKDP-1, IFN-tau, Ets-2 and C/EBP-beta mRNA in sheep trophectoderm. RT reactions were performed on sheep trophoblast RNA collected from different days of pregnancy. After binding to oligo dT primer, reverse transcription and PCR amplification with primers specific for each message were performed. A) Comparison of ovTKDP-1 and IFN-tau expression during the peri-implantation period of conceptus development. Lanes 1-3: positive control PCR with TKDP-1, IFN-tau and S25 plasmid templates, respectively; lanes 4-9: PCR with days 14, 15, 16, 17, 19 and 25 sheep trophoblast cDNA. B) Ets-2 mRNA expression during the peri-implantation period of conceptus development. Lane 1: DNA marker; lane 2: positive control PCR with Ets-2 expression plasmid; lanes 3-8: PCR with day 14, 15, 16, 17 and 25 cDNA. C) C/EBP-beta mRNA expression;. Lane 1: DNA marker; lane 2: positive control PCR with C/EBPbeta expression plasmid; lanes 3-8: PCR with day 14, 15, 16, 17 and 25 cDNA.
###end p 153
###begin p 154
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of a series of <italic>Tkdp-1 </italic>promoter-<italic>Luc </italic>reporter constructs transfected into JEG-3 cells</bold>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
Expression of a series of Tkdp-1 promoter-Luc reporter constructs transfected into JEG-3 cells. Luc activities are expressed relative to that of the promoter-less pGL2-Basic Luc reporter construct, with data shown as means +/- SEM (n = 3; P < 0.05: pGL2 vs. 1000, 352, 254, 192, 140).
###end p 154
###begin p 155
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ovTkdp-1 </italic>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boIFNT1 </italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Possible transcription factor-binding sites in the proximal <italic>ovTkdp-1 </italic>and <italic>boIFNT1 </italic>promoters</bold>
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boIFNT1 </italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tsp </italic>
Possible transcription factor-binding sites in the proximal ovTkdp-1 and boIFNT1 promoters. The sequence of the Ets-AP-1 composite enhancer in the boIFNT1 promoter is also shown [23]. The tsp is designated +1.
###end p 155
###begin p 156
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transactivation of the <italic>Tkdp-1 </italic>promoter by Ets-2</bold>
###xml 49 52 49 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 426 429 424 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 489 490 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 501 508 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 517 521 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 575 579 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 889 892 885 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 968 975 964 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 984 988 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 1008 1012 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
Transactivation of the Tkdp-1 promoter by Ets-2. A) Effects of different Ets family transcription factors on reporter expression from the 1000 bp Tkdp-1 promoter-Luc reporter construct in JEG-3 cells. Luc activities (means +/- SEM; n = 3) are expressed relative to that of the basal activity of the 1000 bp construct. Following values differ significantly (p < 0.05): 1000 vs. 1000+Ets-1 and Ets-2; 1000+Ets-1 vs. 1000+Ets-2. B) Effect of Ets-2 on the transcriptional activities of three 5/-truncated Tkdp-1 promoter-Luc reporter constructs 1000, 352 and 140 in JEG-3 cells. Luc activities are expressed relative to that of the basal activity of each of the truncated constructs and data are shown as mean +/- SEM (n = 3). For each truncated construct, the fold-induction in reporter activity after co-transfection with Ets-2 is significantly different from that without Ets-2 (P < 0.05). C) Effect of increasing concentrations of Ets-2 on the activity of the 1000 bp Tkdp-1 promoter-Luc reporter construct. Luc activities are expressed relative to that of the basal activity of the 1000 bp construct and data are shown as mean +/- SEM (n = 3). Following values differ significantly (p < 0.05): 1000 vs. 0.5 mug, 0.9 mug, 1.3 mug and 1.5 mug Ets-2.
###end p 156
###begin p 157
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of Ets-2 and activated Ras on the <italic>Tkdp-1 </italic>1000 bp promoter activity in NIH3T3 cells</bold>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
Effects of Ets-2 and activated Ras on the Tkdp-1 1000 bp promoter activity in NIH3T3 cells. Luc activities are expressed relative to that of the basal activity of the 1000 bp construct. Data are shown as means +/- SEM (n = 3). The following values differ significantly (p < 0.05): 1000 vs. Ets-2+Ras and T-A72Ets-2+Ras; Ets-2+Ras vs. T-A72Ets-2+Ras.
###end p 157
###begin p 158
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of Ets-2 and activated PKA on the <italic>Tkdp-1 </italic>1000 bp promoter activity in JEG-3 cells</bold>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 140 143 140 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 286 289 286 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 579 582 577 580 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 730 733 728 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
Effects of Ets-2 and activated PKA on the Tkdp-1 1000 bp promoter activity in JEG-3 cells. Expression of the 1000 bp promoter-Luc construct A) following co-transfection with activated PKA, activated PKA+PKI, mutPKA, Ets-2, Ets-2+activated PKA, Ets-2+activated PKA+PKI, Ets-2+mutPKA and B) in cells exposed to the PKA inhibitor H89 in presence and absence of co-transfected Ets-2. Luc activities are expressed relative to that of the basal activity of the 1000 bp construct and data are shown as mean +/- SEM (n = 3). The following values are significantly different at P < 0.05: A) 1000 vs. 1000+PKA, 1000+Ets-2, 1000+Ets-2+PKA; 1000+PKA vs. 1000+mutPKA, 1000+PKA+PKI; 1000+Ets-2+PKA vs. 1000+Ets-2+mutPKA, 1000+Ets-2+PKA+PKI and B) 1000+PKA vs. 1000+PKA+3 muMH89, 1000+PKA+8 muMH89; 1000+PKA+12 muM H89; 1000+Ets-2+PKA vs. 1000+Ets-2+PKA+3 muM H89, 1000+Ets-2+PKA+8 muM H89, 1000+Ets-2+PKA+12 muM H89
###end p 158
###begin p 159
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Competition EMSA with recombinant Ets-2 protein and a <sup>32</sup>P-labeled ds Ets-2 consensus oligonucleotide</bold>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
Competition EMSA with recombinant Ets-2 protein and a 32P-labeled ds Ets-2 consensus oligonucleotide. Lane 1: labeled oligonucleotide+Ets-2-GST-fusion protein; lane 2: labeled oligonucleotide+GST protein; lane 3: labeled oligonucleotide+Ets-2-GST-fusion protein+anti-Ets-2 IgG; lane 4: labeled oligonucleotide+Ets-2-GST-fusion protein+unlabeled Ets-2 consensus oligonucleotide (250-fold molar excess); lanes 5-10: labeled oligonucleotide+Ets-2-GST-fusion protein+unlabeled overlapping oligonucleotides from the Tkdp-1 promoter (-150 to +20) at 250-fold molar excess.
###end p 159
###begin p 160
###xml 48 55 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 0 94 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of C/EBP-&#945;, -&#946; and -&#948; on the <italic>Tkdp-1 </italic>140 bp promoter activity in JEG-3 cells</bold>
###xml 96 100 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 198 201 187 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 257 260 246 249 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 322 326 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 519 522 505 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 596 599 571 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
Effects of C/EBP-alpha, -beta and -delta on the Tkdp-1 140 bp promoter activity in JEG-3 cells. Luc expression driven by the minimal promoter in cells co-transfected with each of the C/EBP isoforms A) in the absence and presence of over-expressed Ets-2 and B) in the presence of over-expressed Ets-2 and 250 muM 8-BrcAMP. Luc activities are expressed relative to that of the basal activity of the 140 bp promoter and data are shown as mean +/- SEM (n = 3). The following values are significantly different at P < 0.05: A) 140 vs. Ets-2, C/EBP-alpha+Ets-2, C/EB-Pbeta+Ets-2, C/EBP-delta+Ets-2 and B) 140 vs. cAMP+Ets-2, cAMP+Ets-2+C/EBP-alpha, cAMP+Ets-2+C/EBP-beta, cAMP+Ets-2+C/EBP-delta; cAMP+Ets-2 vs. cAMP+Ets-2+C/EBP-beta, cAMP+Ets-2+C/EBP-delta. cAMP+Ets-2+C/EBP-beta is significantly different (P < 0.05) from both cAMP+Ets-2+C/EBP-alpha and cAMP+ Ets-2+C/EBP-delta.
###end p 160
###begin p 161
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 0 132 0 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of the CCAAT/enhancer element (-117 to -109) mutation on the <italic>Tkdp-1 </italic>140 bp promoter activity in A) JEG-3 and B) NIH3T3 cells</bold>
###xml 134 137 134 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 275 278 275 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 602 605 600 603 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 711 714 709 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
Effects of the CCAAT/enhancer element (-117 to -109) mutation on the Tkdp-1 140 bp promoter activity in A) JEG-3 and B) NIH3T3 cells. A) Basal, activated PKA, Ets-2, Ets-2+activated PKA-dependent activation of the wild type and C/EBP-mutated minimal promoter in JEG-3 cells. B) Basal, activated Ras, Ets-2, Ets-2+activated Ras-dependent activation of the wild type and C/EBP-mutated promoter in NIH3T3 cells. Luc activities are expressed relative to that of the basal activity of the 140 bp promoter and data are shown as mean +/- SEM (n = 3). Following values are significantly different at P < 0.05: A) 140+PKA vs. C/EBPmut140+PKA; 140+Ets-2 vs. C/EBPmut140+Ets-2; 140+Ets-2+PKA vs. C/EBPmut140+Ets-2+PKA and B) 140+Ets-2 vs. C/EBPmut140+Ets-2 and 140+Ets-2+Ras vs. C/EBPmut140+Ets-2+Ras.
###end p 161
###begin p 162
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EMSA with <sup>32</sup>P-labeled C/EBP oligonucleotide (-117 to -109) and JEG-3 cell extracts (CE)</bold>
###xml 362 368 <span type="species:ncbi:9986">rabbit</span>
EMSA with 32P-labeled C/EBP oligonucleotide (-117 to -109) and JEG-3 cell extracts (CE). Lane 1: labeled oligonucleotide+CE; lane 2: labeled oligonucleotide-CE; lane 3: labeled oligonucleotide+CE+C/EBP-alpha IgG; lane 4: labeled oligonucleotide+CE+C/EBP-beta IgG; lane 5: labeled oligonucleotide+CE+C/EBP-delta IgG; lane 6: labeled oligonucleotide+CE+non-immune rabbit IgG; lanes 7-8: labeled oligonucleotide+CE+250-fold molar excess of unlabeled wild type (lane 7) and mutated (lane 8) C/EBP competitor oligonucleotides.
###end p 162
###begin p 163
###xml 0 185 0 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C/EBP-&#946; and Ets-2 interaction demonstrated by A) co-immunoprecipitation, B) and C) pull-down assays with biotinylated C/EBP oligonucleotide (-117 to -109) in JEG-3 cell extracts (CE)</bold>
###xml 187 190 184 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 469 472 460 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 927 930 915 918 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 378 384 <span type="species:ncbi:9986">rabbit</span>
C/EBP-beta and Ets-2 interaction demonstrated by A) co-immunoprecipitation, B) and C) pull-down assays with biotinylated C/EBP oligonucleotide (-117 to -109) in JEG-3 cell extracts (CE). A) Lane 1: JEG-3 CE (positive control for western blot); lane 2: immunoprecipitation (IP) with C/EBP-beta IgG (positive control for IP); lane 3: IP with Ets-2 IgG; lane 4: IP with non-immune rabbit IgG (negative control for IP). Western blot (WB) was performed with C/EBP-beta IgG. B) WB performed with C/EBP-beta IgG as detection reagent following pull-down assays. Lane 1: JEG-3 CE (positive control for WB); lane 2: biotinylated C/EBP oligonucleotide; lane 3: JEG-3 CE+biotinylated C/EBP oligonucleotide; lane 4: JEG-3 CE+biotinylated C/EBP oligonucleotide+250-fold molar excess unlabeled mutated C/EBP oligonucleotide; lane 5: JEG-3 CE+biotinylated C/EBP oligonucleotide+250-fold molar excess unlabeled wild type C/EBP oligonucleotide. C) WB with Ets-2 IgG as the detection agent following pull-down assays. Lane 1: JEG-3 CE (positive control for WB); lane 2: biotinylated C/EBP oligonucleotide; lane 3: JEG-3 CE+biotinylated C/EBP oligonucleotide; lane 4: JEG-3 CE+biotinylated C/EBP oligonucleotide+250-fold molar excess unlabeled wild type C/EBP oligonucleotide.
###end p 163
###begin p 164
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1</italic>
###xml 0 103 0 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Importance of the AP-1 element (-99 to -93) for the <italic>Tkdp-1</italic>.140 bp promoter activity in JEG-3 cells. A) </bold>
###xml 234 241 234 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tkdp-1 </italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc </italic>
###xml 553 556 551 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 560 563 558 561 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 638 645 636 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tkdp-1 </italic>
###xml 744 747 742 745 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 766 769 761 764 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
Importance of the AP-1 element (-99 to -93) for the Tkdp-1.140 bp promoter activity in JEG-3 cells. A) Effects of the AP-1 element mutation on the basal, activated PKA, Ets-2 and Ets-2+activated PKA-dependent activation of the 140 bp Tkdp-1 promoter-Luc reporter construct in JEG-3 cells. Luc activities are expressed relative to that of the basal activity of the 140 bp promoter and data are shown as mean +/- SEM (n = 3). Following values are significantly different at P < 0.05: 140+PKA vs. AP-1mut140+PKA and 140+Ets-2+PKA vs. AP-1mut140+Ets-2+PKA. B) and C) Pull-down assays with biotinylated AP-1 oligonucleotide (-99 to -93 in the tkdp-1 promoter) and JEG-3 cell extracts(CE). Following pull-down a ssays, WB analysis was performed with B) C/EBP-beta IgG and C) pan-Jun IgG. Lane 1: JEG-3 CE (positive control for WB); lane 2: biotinylated AP-1 oligonucleotide; lane 3: JEG-3 CE+biotinylated AP-1 oligonucleotide. The molecular weight standards are shown on the left-hand side.
###end p 164

